AstraZeneca has voluntarily withdrawn its marketing authorisation application with the EU's medicines regulator for its ...

Biocon Ltd and its European partner, Zentiva, have received a decentralised procedure approval in the European Union for ...

European stocks edged higher in cautious trade on Tuesday ahead of Christmas break. The German DAX is not trading today while the ...

Anavex Life Sciences Corp (AVXL) reports a robust cash runway and significant progress in Alzheimer's research, despite ...

Biocon and Zentiva receive EU approval for generic versions of Victoza (diabetes) and Saxenda (weight management). This marks ...

U.K. stocks were moving higher on Tuesday in thin-shortened trading session for Christmas Eve. Markets will remain shut on Wednesday ...

AstraZeneca said it and Daiichi Sankyo decided to voluntarily withdraw the marketing authorization application in the European Union for advanced lung-cancer treatment Dato-DXd. This decision followed ...

AstraZeneca has pulled its European marketing authorisation application for its non-small cell lung cancer treatment based on ...

Cytokinetics (NASDAQ:CYTK) said EU regulators have validated the market application for its drug aficamten for the treatment ...

Biocon Ltd, in collaboration with Zentiva, has obtained EU approval for the complex formulation Liraglutide, a generic ...

The European MCL Network Phase 3 TRIANGLE study, evaluated ibrutinib in combination with induction immunochemotherapy, both with and without an autologous stem cell transplant, followed by 24 months f ...